Mining mammalian genes

Credit: Courtesy of Piero Carninci" /> Credit: Courtesy of Piero Carninci The paper: The FANTOM Consortium and RIKEN, "The transcriptional landscape of the mammalian genome," Science, 309:1559-63, 2005. (Cited in 251 papers) The finding: Techniques such as cap-analysis gene-expression and gene-identification signature technology allowed a group led by Yoshihide Hayashizaki at the RIKEN Institute in Wako, Japan, to look more in-depth at the mouse tran

Written byKelly Rae Chi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:
The FANTOM Consortium and RIKEN, "The transcriptional landscape of the mammalian genome," Science, 309:1559-63, 2005. (Cited in 251 papers)

The finding:
Techniques such as cap-analysis gene-expression and gene-identification signature technology allowed a group led by Yoshihide Hayashizaki at the RIKEN Institute in Wako, Japan, to look more in-depth at the mouse transcriptome. The team identified more than 180,000 RNA transcripts, which varied extensively based on alternative splicing and other modifications. Grouping these sequences into 44,000 transcript groups, they found that more than half did not code for proteins.

The significance:
The large variation in transcript modifications suggests that "mammalian genome RNA output is much more complex that previously thought," writes coauthor Piero Carninci in an E-mail. The study was "really the first" to start explaining how such complex mammalian systems can be encoded by so few genes, says Merete Fredholm of the University of Copenhagen.

The companion study: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies